These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33793383)

  • 1. Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment.
    Bolletta E; Gozzi F; Mastrofilippo V; Pipitone N; De Simone L; Croci S; Invernizzi A; Adani C; Iannetta D; Coassin M; Fontana L; Salvarani C; Cimino L
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1303-1308. PubMed ID: 33793383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Enhanced Depth Imaging and Swept Source Optical Coherence Tomography in Assessment of Choroidal Thickness in Vogt-Koyanagi-Harada Disease.
    Chee SP; Chan SN; Jap A
    Ocul Immunol Inflamm; 2017 Aug; 25(4):528-532. PubMed ID: 27070488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of B Cell Depletion Therapy with Rituximab in Refractory Chronic Recurrent Uveitis Associated with Vogt-Koyanagi-Harada Disease.
    Abu El-Asrar AM; Dheyab A; Khatib D; Struyf S; Van Damme J; Opdenakker G
    Ocul Immunol Inflamm; 2022 Apr; 30(3):750-757. PubMed ID: 32990482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease.
    Nakayama M; Keino H; Okada AA; Watanabe T; Taki W; Inoue M; Hirakata A
    Retina; 2012; 32(10):2061-9. PubMed ID: 23095726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUBFOVEAL CHOROIDAL THICKNESS IN PAPILLITIS TYPE OF VOGT-KOYANAGI-HARADA DISEASE AND IDIOPATHIC OPTIC NEURITIS.
    Maruko I; Iida T; Sugano Y; Go S; Sekiryu T
    Retina; 2016 May; 36(5):992-9. PubMed ID: 26509220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widefield Swept-Source OCTA in Vogt-Koyanagi-Harada Disease.
    Vingopoulos F; Cui Y; Katz R; Le R; Zhu Y; Wang JC; Lu Y; Sobrin L; Miller JB
    Ophthalmic Surg Lasers Imaging Retina; 2020 Jul; 51(7):407-412. PubMed ID: 32706899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of choriocapillary vascular density measured by optical coherence tomography angiography in Vogt-Koyanagi-Harada disease.
    Liang A; Jia S; Gao F; Han X; Pei M; Qu Y; Xiao J; Zhao C; Zhang M
    Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3395-3404. PubMed ID: 34216256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis.
    Elhamaky TR
    Indian J Ophthalmol; 2022 Jul; 70(7):2465-2470. PubMed ID: 35791135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease.
    Jap A; Chee SP
    Br J Ophthalmol; 2017 Feb; 101(2):186-189. PubMed ID: 27048179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of choroidal structure after corticosteroid treatment in eyes with Vogt-Koyanagi-Harada disease.
    Egawa M; Mitamura Y; Akaiwa K; Semba K; Kinoshita T; Uchino E; Sonoda S; Sakamoto T
    Br J Ophthalmol; 2016 Dec; 100(12):1646-1650. PubMed ID: 26906951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
    Nakai K; Gomi F; Ikuno Y; Yasuno Y; Nouchi T; Ohguro N; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1089-95. PubMed ID: 22240936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Need for Quantitative Measurement Methods for Posterior Uveitis: Comparison of Dual FA/ICGA Angiography, EDI-OCT Choroidal Thickness and SUN Vitreous Haze Evaluation in Stromal Choroiditis.
    Fabro F; Herbort CP
    Klin Monbl Augenheilkd; 2018 Apr; 235(4):424-435. PubMed ID: 29669371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autofluorescence combined with spectral domain optical coherence tomography for diagnosis and follow-up of acute Vogt-Koyanagi-Harada disease].
    Tian S; Yao J; Wang J; Zhang J; Zhou A
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):135-140. PubMed ID: 33509766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
    Herbort CP; Mantovani A; Bouchenaki N
    Int Ophthalmol; 2007; 27(2-3):173-82. PubMed ID: 17457515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed-onset unilateral Vogt-Koyanagi-Harada syndrome: a multimodal imaging appraisal.
    Verma S; Thakur H; Azad SV; Kumar V
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33568408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Three-Dimensional Choroidal Volume with Enhanced Depth Imaging Findings in Patients with Recurrent Vogt-Koyanagi-Harada Disease.
    Silpa-Archa S; Ittharat W; Chotcomwongse P; Preble JM; Foster CS
    Curr Eye Res; 2021 Jul; 46(7):1010-1017. PubMed ID: 33215546
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging.
    Fukutsu K; Namba K; Iwata D; Mizuuchi K; Kase S; Suzuki K; Shimizu H; Shibata Y; Yamawaki F; Onozawa M; Ishida S
    BMC Ophthalmol; 2020 Mar; 20(1):94. PubMed ID: 32156266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
    Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
    Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.
    Maruko I; Iida T; Sugano Y; Oyamada H; Sekiryu T; Fujiwara T; Spaide RF
    Retina; 2011 Mar; 31(3):510-7. PubMed ID: 20948460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full-field electroretinogram behavior in Vogt-Koyanagi-Harada disease: a 24-month longitudinal study in patients from acute onset evaluated with multimodal analysis.
    Sakata VM; Lavezzo MM; da Silva FT; Rodriguez EEC; Morita C; Abdallah SF; Oyamada MK; Hirata CE; Yamamoto JH
    Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2285-2295. PubMed ID: 31440820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.